Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

August 30, 2024 by Alan Khadavi

Covid Vaccine with Fasenra, Dupixent or Nucala

Can the covid vaccine be given with Fasenra, Dupixent or Nucala?

Within the first year of the COVID 19 pandemic, two vaccines were approved for FDA emergency use by Pfizer and Moderna. Patients who have severe asthma may be on biologic immunomodulators which may affect the immune response to these vaccines. The cytokines that are affected by them are IL-4, IL-5 and IL-13 which also may play a role in normal immunity. Most biologic treatments are not generally associated with major risks of viral or bacterial infections, but a recent study published in The Journal of Allergy and Clinical Immunology, Volume 154. No. 2, August 2024 titled “Patients taking benralizumab, dupilumab or mepolizumab have lower postvaccination SARS-CoV-2 immunity” examined this.

Patients who have severe asthma or eczema who were taking Fasenra, Dupixent or Nucala received either mRNA vaccine and were compared to a control group of healthy subjects who were not taking any biologics. Patients who are on these biologic medications typically have severe symptoms and and exacerbations which led them to starting these medications and they have led to improved quality of life.

The patients who were on one of the biologics had reduced SARS-CoV-2 specific antibody titers, neutralizing activity and virus specific B and CD8 T Cell counts. These results have implications for those who are on the medications who will receive the COVID vaccines.

The inhibition of the IL-4 or IL-5 pathways is associated with less immunity. Because each biologic has a different mechanism of action targeting different molecules and receptors, the mechanism of impairment of postvaccination immunity for each biologic will likely be different.

This could place those subjects who are on benralizumab, dupilumab, or mepolizumab at increased risk of COVID-19 infection despite vaccination.

Update October 8, 2024

A recent study looked at patients on Dupixent receiving live vaccines.  The package insert recommend that patients who are being treated with Dupixent should avoid live vaccines.  The available literature on patients who received vaccinations while using Dupixent overall suggests that live vaccines are safe and the vaccine efficacy, in general, is not affected by dupilumab. It is suggested, receiving Dupixent and the use of vaccines (including live ones) is likely safe and effective. This is a decision that a patient and doctor should decide together.

Can the Covid Vaccine cause Hives?

Allergic Reactions to Covid Vaccines an update

Moderna Covid Vaccine and Allergy

New Asthma Drug Nucala (Mepolizumab) for Severe Eosinophilic Asthma

Dupilumab (Dupixent) for Atopic Dermatitis (Eczema) Sufferers

Fasenra (Benralizumab) for Severe Asthma

Filed Under: biologics, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page